Amygdalin as a Potential Anti-Cancer Agent: A Concise Review of Therapeutic Insights and Mechanisms

Amygdalin, also known as laetrile, has generated significant controversy within the scientific medical community regarding its efficacy as a cancer treatment. Extracted primarily from the seeds of fruits like apricots and almonds, it has been promoted by certain groups as a potential cure for cancer despite criticism regarding its toxicity and minimal therapeutic value. This review aims to analyze the available literature on amygdalin, focusing on its chemical characteristics, proposed mechanisms of action, and its role in cancer prevention and therapy. A comprehensive review of preclinical data and clinical trials was conducted to assess amygdalin's potential effects and associated risks. The analysis of existing studies provides insights into the complexity of amygdalin's biological activity, including its interactions and suggested pathways in cancer treatment, while highlighting the need for further research to clarify its efficacy and safety. Ultimately, the review contributes to the ongoing discussion surrounding amygdalin's position in oncology and emphasizes the necessity for continued exploration to develop effective cancer treatment strategies.